東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Mitochondrial mechanisms of degenera...

Buhlman, Lori M.

FindBook

Google Book

Amazon

博客來

Mitochondrial mechanisms of degeneration and repair in Parkinson's disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Mitochondrial mechanisms of degeneration and repair in Parkinson's disease/ edited by Lori M. Buhlman.
其他作者:	Buhlman, Lori M.
出版者:	Cham :Springer International Publishing : : 2016.,
面頁冊數:	xii, 275 p. :ill., digital ;24 cm.
內容註:	Mitochondrial ROS and Apoptosis -- Dopamine Metabolism and Reactive Oxygen Species Production -- The Consequences of Damaged Mitochondrial DNA -- The role of chronic inflammation in the etiology of Parkinson's disease -- Ion-Catalyzed Reactive Oxygen Species in Sporadic Models of Parkinson's Disease -- Toxin Mediated Complex I Inhibition and Parkinson's Disease -- Parkinson Disease-Associated Mutations Affect Mitochondrial Function -- PARKIN/PINK1 Pathway for the Selective Isolation and Degradation of Impaired Mitochondria -- Mitochondrial Therapeutic approaches in Parkinson's Disease -- Altering Mitochondrial Fusion and Fission Protein Levels Rescues Parkin and PINK1 Loss-of-Function Phenotypes -- Early Nicotine Exposure is Protective in Familial and Idiopathic Models of Parkinson's Disease -- Transcription Modulation of Mitochondrial Function and Related Pathways as a Therapeutic Opportunity in Parkinson's Disease -- Delivery of Biologically Active Molecules to Mitochondria.
Contained By:	Springer eBooks
標題:	Parkinson's disease - Molecular aspects. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-42139-1
ISBN:	9783319421391$q(electronic bk.)

Mitochondrial mechanisms of degeneration and repair in Parkinson's disease
Mitochondrial mechanisms of degeneration and repair in Parkinson's disease[electronic resource] /edited by Lori M. Buhlman. - Cham :Springer International Publishing :2016. - xii, 275 p. :ill., digital ;24 cm.

Mitochondrial ROS and Apoptosis -- Dopamine Metabolism and Reactive Oxygen Species Production -- The Consequences of Damaged Mitochondrial DNA -- The role of chronic inflammation in the etiology of Parkinson's disease -- Ion-Catalyzed Reactive Oxygen Species in Sporadic Models of Parkinson's Disease -- Toxin Mediated Complex I Inhibition and Parkinson's Disease -- Parkinson Disease-Associated Mutations Affect Mitochondrial Function -- PARKIN/PINK1 Pathway for the Selective Isolation and Degradation of Impaired Mitochondria -- Mitochondrial Therapeutic approaches in Parkinson's Disease -- Altering Mitochondrial Fusion and Fission Protein Levels Rescues Parkin and PINK1 Loss-of-Function Phenotypes -- Early Nicotine Exposure is Protective in Familial and Idiopathic Models of Parkinson's Disease -- Transcription Modulation of Mitochondrial Function and Related Pathways as a Therapeutic Opportunity in Parkinson's Disease -- Delivery of Biologically Active Molecules to Mitochondria.

This volume brings together various theories of how aberrations in mitochondrial function and morphology contribute to neurodegeneration in idiopathic and familial forms of Parkinson's disease. Moreover, it comprehensively reviews the current search for therapies, and proposes how molecules are involved in specific functions as attractive therapeutic targets. It is expected to facilitate critical thought and discussion about the fundamental aspects of neurodegeneration in Parkinson's disease and foster the development of therapeutic strategies among researchers and graduate students. Theories of idiopathic Parkinson's etiology support roles for chronic inflammation and exposure to heavy metals or pesticides. Interestingly, as this project proposes, a case can be made that abnormalities in mitochondrial morphology and function are at the core of each of these theories. In fact, the most common approach to the generation of animal and cell-culture models of idiopathic Parkinson's disease involves exposure to mitochondrial toxins. Even more compelling is the fact that most familial patients harbor genetic mutations that cause disruptions in normal mitochondrial morphology and function. While there remains to be no effective treatment for Parkinson's disease, efforts to postpone, prevent and "cure" onset mitochondrial aberrations and neurodegeneration associated with Parkinson's disease in various models are encouraging. While only about ten percent of Parkinson's patients inherit disease-causing mutations, discovering common mechanisms by which familial forms of Parkinson's disease manifest will likely shed light on the pathophysiology of the more common idiopathic form and provide insight to the general process of neurodegeneration, thus revealing therapeutic targets that will become more and more accessible as technology improves.

ISBN: 9783319421391$q(electronic bk.)

Standard No.: 10.1007/978-3-319-42139-1doiSubjects--Topical Terms:

3135863
Parkinson's disease
--Molecular aspects.

LC Class. No.: RC382

Dewey Class. No.: 616.833

Mitochondrial mechanisms of degeneration and repair in Parkinson's disease
LDR:03814nmm a2200313 a 4500 001 2052477
003 DE-He213
005 20160913170544.0
006 m d
007 cr nn 008maaau
008 170421s2016 gw s 0 eng d
020 $a 9783319421391$q(electronic bk.)
020 $a 9783319421377$q(paper)
024 7 $a 10.1007/978-3-319-42139-1 $2 doi
035 $a 978-3-319-42139-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC382
072 7 $a MJN $2 bicssc
072 7 $a MED057000 $2 bisacsh
082 0 4 $a 616.833 $2 23
090 $a RC382 $b .M684 2016
245 0 0 $a Mitochondrial mechanisms of degeneration and repair in Parkinson's disease $h [electronic resource] / $c edited by Lori M. Buhlman.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xii, 275 p. : $b ill., digital ; $c 24 cm.
505 0 $a Mitochondrial ROS and Apoptosis -- Dopamine Metabolism and Reactive Oxygen Species Production -- The Consequences of Damaged Mitochondrial DNA -- The role of chronic inflammation in the etiology of Parkinson's disease -- Ion-Catalyzed Reactive Oxygen Species in Sporadic Models of Parkinson's Disease -- Toxin Mediated Complex I Inhibition and Parkinson's Disease -- Parkinson Disease-Associated Mutations Affect Mitochondrial Function -- PARKIN/PINK1 Pathway for the Selective Isolation and Degradation of Impaired Mitochondria -- Mitochondrial Therapeutic approaches in Parkinson's Disease -- Altering Mitochondrial Fusion and Fission Protein Levels Rescues Parkin and PINK1 Loss-of-Function Phenotypes -- Early Nicotine Exposure is Protective in Familial and Idiopathic Models of Parkinson's Disease -- Transcription Modulation of Mitochondrial Function and Related Pathways as a Therapeutic Opportunity in Parkinson's Disease -- Delivery of Biologically Active Molecules to Mitochondria.
520 $a This volume brings together various theories of how aberrations in mitochondrial function and morphology contribute to neurodegeneration in idiopathic and familial forms of Parkinson's disease. Moreover, it comprehensively reviews the current search for therapies, and proposes how molecules are involved in specific functions as attractive therapeutic targets. It is expected to facilitate critical thought and discussion about the fundamental aspects of neurodegeneration in Parkinson's disease and foster the development of therapeutic strategies among researchers and graduate students. Theories of idiopathic Parkinson's etiology support roles for chronic inflammation and exposure to heavy metals or pesticides. Interestingly, as this project proposes, a case can be made that abnormalities in mitochondrial morphology and function are at the core of each of these theories. In fact, the most common approach to the generation of animal and cell-culture models of idiopathic Parkinson's disease involves exposure to mitochondrial toxins. Even more compelling is the fact that most familial patients harbor genetic mutations that cause disruptions in normal mitochondrial morphology and function. While there remains to be no effective treatment for Parkinson's disease, efforts to postpone, prevent and "cure" onset mitochondrial aberrations and neurodegeneration associated with Parkinson's disease in various models are encouraging. While only about ten percent of Parkinson's patients inherit disease-causing mutations, discovering common mechanisms by which familial forms of Parkinson's disease manifest will likely shed light on the pathophysiology of the more common idiopathic form and provide insight to the general process of neurodegeneration, thus revealing therapeutic targets that will become more and more accessible as technology improves.
650 0 $a Parkinson's disease $x Molecular aspects. $3 3135863
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Neurochemistry. $3 657592
650 2 4 $a Neurobiology. $3 588707
650 2 4 $a Neurology. $3 588698
700 1 $a Buhlman, Lori M. $3 3135862
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-42139-1
950 $a Biomedical and Life Sciences (Springer-11642)